Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebahattin Yurdakul

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Rheumatology International|January 12, 2018
Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studiesGizem Ayan, Sinem Nihal Esatoglu, Gulen Hatemi, et al.
Seminars in Arthritis and Rheumatism|January 29, 2008
Atherosclerosis in Behçet's SyndromeEmire Seyahi, Serdal Ugurlu, Rana Cumali, et al.
Rheumatology (Oxford, England)|December 17, 2019
Long term follow-up of Behçet's syndrome patients treated with cyclophosphamideMert Gurcan, Sinem Nihal Esatoglu, Vedat Hamuryudan, et al.
Rheumatology (Oxford, England)|June 3, 2022
Frequency of AA amyloidosis has decreased in Behçet's syndrome: a retrospective study with long-term follow-up and a systematic reviewGuzin Karatemiz, Sinem Nihal Esatoglu, Mert Gurcan, et al.
Clinical Immunology (Orlando, Fla.)|June 29, 2023
Infliximab for vascular involvement in Behçet's syndromeGulen Hatemi, Nur Beyza Tukek, Sinem Nihal Esatoglu, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Biosimilar infliximab for Behçet's syndrome: a case seriesElif Dincses, Sinem Nihal Esatoglu, Yesim Ozguler, et al.
Rheumatology International|July 6, 2021
Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination ratesAysa Hacioglu, Sermin Borekci, Melike Melikoglu, et al.
Rheumatology (Oxford, England)|December 27, 2021
Emergence of new manifestations during infliximab treatment in Behçet's syndromeNur Beyza Tukek, Sinem Nihal Esatoglu, Gulen Hatemi, et al.
Annals of the Rheumatic Diseases|April 8, 2018
2018 update of the EULAR recommendations for the management of Behçet's syndromeGulen Hatemi, Robin Christensen, Dongsik Bang, et al.
Seminars in Arthritis and Rheumatism|June 30, 2018
Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndromePietro Leccese, Yesim Ozguler, Robin Christensen, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Rheumatology International|January 12, 2018
Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studiesGizem Ayan, Sinem Nihal Esatoglu, Gulen Hatemi, et al.
Seminars in Arthritis and Rheumatism|January 29, 2008
Atherosclerosis in Behçet's SyndromeEmire Seyahi, Serdal Ugurlu, Rana Cumali, et al.
Rheumatology (Oxford, England)|December 17, 2019
Long term follow-up of Behçet's syndrome patients treated with cyclophosphamideMert Gurcan, Sinem Nihal Esatoglu, Vedat Hamuryudan, et al.
Rheumatology (Oxford, England)|June 3, 2022
Frequency of AA amyloidosis has decreased in Behçet's syndrome: a retrospective study with long-term follow-up and a systematic reviewGuzin Karatemiz, Sinem Nihal Esatoglu, Mert Gurcan, et al.
Clinical Immunology (Orlando, Fla.)|June 29, 2023
Infliximab for vascular involvement in Behçet's syndromeGulen Hatemi, Nur Beyza Tukek, Sinem Nihal Esatoglu, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Biosimilar infliximab for Behçet's syndrome: a case seriesElif Dincses, Sinem Nihal Esatoglu, Yesim Ozguler, et al.
Rheumatology International|July 6, 2021
Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination ratesAysa Hacioglu, Sermin Borekci, Melike Melikoglu, et al.
Rheumatology (Oxford, England)|December 27, 2021
Emergence of new manifestations during infliximab treatment in Behçet's syndromeNur Beyza Tukek, Sinem Nihal Esatoglu, Gulen Hatemi, et al.
Annals of the Rheumatic Diseases|April 8, 2018
2018 update of the EULAR recommendations for the management of Behçet's syndromeGulen Hatemi, Robin Christensen, Dongsik Bang, et al.
Seminars in Arthritis and Rheumatism|June 30, 2018
Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndromePietro Leccese, Yesim Ozguler, Robin Christensen, et al.
Pageof 4